home / openregs / federal_register

federal_register: 94-6292

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
94-6292 Drug Export; Serzone (Nefazodone HCl) Tablets 50 mg, 100 mg, 150 mg, 200 mg, and 300 mg Uncategorized Document The Food and Drug Administration (FDA) is announcing that Bristol-Myers Squibb has filed an application requesting approval for the export of the human drug Serzone (nefazodone HCl) 50 mg, 100 mg, 150 mg, 200 mg, and 300 mg Tablets to Canada. 1994-03-18 1994 3 https://www.federalregister.gov/documents/1994/03/18/94-6292/drug-export-serzone-nefazodone-hcl-tablets-50-mg-100-mg-150-mg-200-mg-and-300-mg   Health and Human Services Department 221 The Food and Drug Administration (FDA) is announcing that Bristol-Myers Squibb has filed an application requesting approval for the export of the human drug Serzone (nefazodone HCl) 50 mg, 100 mg, 150 mg, 200 mg, and 300 mg Tablets to Canada.

Links from other tables

  • 1 row from document_number in federal_register_agencies
  • 1 row from fr_document_number in fr_regs_crossref
Powered by Datasette · Queries took 10.578ms